Literature DB >> 28229580

Levosimendan in Sepsis.

Heinrich‑Volker Groesdonk1, Michael Sander2, Matthias Heringlake3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28229580     DOI： 10.1056/NEJMc1616632

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial.

Authors:  David B Antcliffe; Shalini Santhakumaran; Robert M L Orme; Josie K Ward; Farah Al-Beidh; Kieran O'Dea; Gavin D Perkins; Mervyn Singer; Daniel F McAuley; Alexina J Mason; Mary Cross; Deborah Ashby; Anthony C Gordon
Journal:  Intensive Care Med       Date:  2019-08-19       Impact factor: 17.440

Review 2.  Inodilators in septic shock: should these be used?

Authors:  Gustavo A Ospina-Tascón; Luis E Calderón-Tapia
Journal:  Ann Transl Med       Date:  2020-06

3.  Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials.

Authors:  Wei Chang; Jian-Feng Xie; Jing-Yuan Xu; Yi Yang
Journal:  BMJ Open       Date:  2018-03-30       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.